Pieris Pharmaceuticals Inc. (Nasdaq: PIRS) entered a research collaboration and license agreement with Roche. The stock price soared 73 cents to close at $2.79.
Pieris Pharmaceuticals enters agreement
December 08, 2015 at 15:55 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.